| abstract |
A fused heterocyclic compound having an enteropeptidase inhibitory effect and a use of the compound as a drug for treating or preventing obesity, diabetes and the like are provided. Specifically, there are provided a compound represented by the following formula (I) (wherein each symbol is as defined herein) or a salt thereof, and use of the compound as a medicament for treating or preventing obesity, diabetes and the like. |